MARCKS c.161C>A ;(p.A54D)

Variant ID: 6-114180917-C-A

NM_002356.5(MARCKS):c.161C>A;(p.A54D)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer.

Nature Communications
Bernasocchi, Tiziano T; El Tekle, Geniver G; Bolis, Marco M; Mutti, Azzurra A; Vallerga, Arianna A; Brandt, Laura P LP; Spriano, Filippo F; Svinkina, Tanya T; Zoma, Marita M; Ceserani, Valentina V; Rinaldi, Anna A; Janouskova, Hana H; Bossi, Daniela D; Cavalli, Manuela M; Mosole, Simone S; Geiger, Roger R; Dong, Ze Z; Yang, Cai-Guang CG; Albino, Domenico D; Rinaldi, Andrea A; Schraml, Peter P; Linder, Simon S; Carbone, Giuseppina M GM; Alimonti, Andrea A; Bertoni, Francesco F; Moch, Holger H; Carr, Steven A SA; Zwart, Wilbert W; Kruithof-de Julio, Marianna M; Rubin, Mark A MA; Udeshi, Namrata D ND; Theurillat, Jean-Philippe P JP
Publication Date: 2021-02-02

Variant appearance in text: MACS: A54D
PubMed Link: 33531470
Variant Present in the following documents:
  • Main text
View BVdb publication page